Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: Glucose and kynurenine

Gastrointestinal Endoscopy

Volumn 78, Issue 2, 2013, Pages

  Park, Walter G ^a   Wu, Manhong ^b   Bowen, Raffick ^a   Zheng, Ming ^b   Fitch, William L ^b   Pai, Reetesh K ^a   Wodziak, Dariusz ^a   Visser, Brendan C ^b   Poultsides, George A ^b   Norton, Jeff A ^b   Banerjee, Subhas ^a   Chen, Ann M ^a   Friedland, Shai ^a   Scott, Brennan A ^c   Pasricha, Pankaj Jay ^a   Lowe, Anson W ^a   Peltz, Gary ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c PALO ALTO MEDICAL FOUNDATION   (United States)

Author keywords

carcinoembryonic antigen; CEA; CI; confidence interval; interquartile range; intraductal papillary mucinous neoplasm; IPMN; IQR; LC MS; liquid chromatography with mass spectrometry; mass spectrometry; MCN; MS; mucinous cystic neoplasm; receiver operating characteristic; ROC; SCA; serous cystadenoma

Indexed keywords

BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN; GLUCOSE; KYNURENINE;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; BENIGN TUMOR; CLINICAL ARTICLE; CYSTADENOMA; CYTOLOGY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FEMALE; GLUCOSE ASSAY; HIGH RISK PATIENT; HISTOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; JAUNDICE; MALE; METABOLOMICS; MUCINOUS CYSTIC NEOPLASM; OUTCOME ASSESSMENT; PANCREAS CYST; PRECANCER; PRIORITY JOURNAL; PSEUDOCYST; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; TUMOR VOLUME; WEIGHT REDUCTION;

EID: 84880315266     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2013.02.037     Document Type: Article

References (20)

1. K. de Jong, C.Y. Nio, and J.J. Hermans High prevalence of pancreatic cysts detected by screening magnetic resonance imaging examinations Clin Gastroenterol Hepatol 8 2010 806 811
2. T.A. Laffan, K.M. Horton, and A.P. Klein Prevalence of unsuspected pancreatic cysts on MDCT AJR Am J Roentgenol 191 2008 802 807
3. B.C. Jacobson, T.H. Baron, and D.G. Adler ASGE guideline: the role of endoscopy in the diagnosis and the management of cystic lesions and inflammatory fluid collections of the pancreas Gastrointest Endosc 61 2005 363 370
4. W.R. Brugge, K. Lewandrowski, and E. Lee-Lewandrowski Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study Gastroenterology 126 2004 1330 1336
5. K. Dettmer, P.A. Aronov, and B.D. Hammock Mass spectrometry-based metabolomics Mass Spectrom Rev 26 2007 51 78
6. K. Guo, and L. Li Differential 12C-/13C-isotope dansylation labeling and fast liquid chromatography/mass spectrometry for absolute and relative quantification of the metabolome Anal Chem 81 2009 3919 3932
7. A. Kunst, B. Draeger, and J. Zeigenhorn UV methods with exokinase and glucose-6-phosphate dehydrogenase H.U. Bergmeyer, Methods of enzymatic analysis. 6 1983 Verlag Chemie Deerfield (Fla) 163 172
8. T. Hastie, R. Tibshirani, and J. Friedman The elements of statistical learning 2001 Springer New York
9. E. Ke, B.B. Patel, and T. Liu Proteomic analyses of pancreatic cyst fluids Pancreas 38 2009 e33 e42
10. J. Wu, H. Matthaei, and A. Maitra Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development Sci Transl Med 3 2011 92ra66
11. J.K. Ryu, H. Matthaei, and M. Dal Molin Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma Pancreatology 11 2011 343 350
12. P.J. Allen, L.X. Qin, and L. Tang Pancreatic cyst fluid protein expression profiling for discriminating between serous cystadenoma and intraductal papillary mucinous neoplasm Ann Surg 250 2009 754 760
13. A. Khalid, M. Zahid, and S.D. Finkelstein Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study Gastrointest Endosc 69 2009 1095 1102
14. L.A. van der Waaij, H.M. van Dullemen, and R.J. Porte Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis Gastrointest Endosc 62 2005 383 389
15. Y. Chen, and G.J. Guillemin Kynurenine pathway metabolites in humans: disease and healthy States Int J Tryptophan Res 2 2009 1 19
16. C.A. Opitz, U.M. Litzenburger, and F. Sahm An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor Nature 478 2011 197 203
17. A. Witkiewicz, T.K. Williams, and J. Cozzitorto Expression of indoleamine 2,3-dioxygenase in metastatic pancreatic ductal adenocarcinoma recruits regulatory T cells to avoid immune detection J Am Coll Surg 206 2008 849 854 discussion 54-6
18. M.G. Vander Heiden Targeting cancer metabolism: a therapeutic window opens Nat Rev Drug Discov 10 2011 671 684
19. M.G. Vander Heiden, S.Y. Lunt, and T.L. Dayton Metabolic pathway alterations that support cell proliferation Cold Spring Harb Symp Quant Biol Jan 19, 2012
20. K. Partyka, M. McDonald, and K.A. Maupin Comparison of surgical and endoscopic sample collection for pancreatic cyst fluid biomarker identification J Proteome Res 11 2012 2904 2911